Analysen zu SAFRAN S.A.
| 12.08.24 | SAFRAN Hold | Deutsche Bank AG | |
| 09.08.24 | SAFRAN Neutral | Goldman Sachs Group Inc. | |
| 07.08.24 | SAFRAN Neutral | UBS AG | |
| 31.07.24 | SAFRAN Neutral | Goldman Sachs Group Inc. | |
| 31.07.24 | SAFRAN Overweight | JP Morgan Chase & Co. | |
| 19.07.24 | SAFRAN Hold | Jefferies & Company Inc. | |
| 18.07.24 | SAFRAN Neutral | Goldman Sachs Group Inc. | |
| 10.07.24 | SAFRAN Hold | Jefferies & Company Inc. | |
| 10.07.24 | SAFRAN Hold | Deutsche Bank AG | |
| 04.07.24 | SAFRAN Neutral | Goldman Sachs Group Inc. | |
| 03.07.24 | SAFRAN Neutral | UBS AG | |
| 24.06.24 | SAFRAN Hold | Jefferies & Company Inc. | |
| 20.06.24 | SAFRAN Overweight | Barclays Capital | |
| 17.06.24 | SAFRAN Hold | Jefferies & Company Inc. | |
| 06.06.24 | SAFRAN Hold | Jefferies & Company Inc. | |
| 07.05.24 | SAFRAN Hold | Deutsche Bank AG | |
| 07.05.24 | SAFRAN Overweight | Barclays Capital | |
| 03.05.24 | SAFRAN Halten | DZ BANK | |
| 30.04.24 | SAFRAN Neutral | Goldman Sachs Group Inc. | |
| 29.04.24 | SAFRAN Hold | Deutsche Bank AG | |
| 29.04.24 | SAFRAN Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 26.04.24 | SAFRAN Neutral | UBS AG | |
| 26.04.24 | SAFRAN Neutral | Goldman Sachs Group Inc. | |
| 26.04.24 | SAFRAN Hold | Jefferies & Company Inc. | |
| 12.04.24 | SAFRAN Neutral | UBS AG | |
| 12.04.24 | SAFRAN Hold | Deutsche Bank AG | |
| 10.04.24 | SAFRAN Hold | Jefferies & Company Inc. | |
| 25.03.24 | SAFRAN Hold | Deutsche Bank AG | |
| 19.03.24 | SAFRAN Hold | Jefferies & Company Inc. | |
| 08.03.24 | SAFRAN Neutral | UBS AG | |
| 06.03.24 | SAFRAN Neutral | UBS AG | |
| 04.03.24 | SAFRAN Overweight | JP Morgan Chase & Co. | |
| 26.02.24 | SAFRAN Hold | Jefferies & Company Inc. | |
| 21.02.24 | SAFRAN Hold | Deutsche Bank AG | |
| 16.02.24 | SAFRAN Halten | DZ BANK | |
| 16.02.24 | SAFRAN Hold | Deutsche Bank AG | |
| 15.02.24 | SAFRAN Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 15.02.24 | SAFRAN Neutral | UBS AG | |
| 15.02.24 | SAFRAN Hold | Jefferies & Company Inc. | |
| 15.02.24 | SAFRAN Overweight | JP Morgan Chase & Co. | |
| 12.02.24 | SAFRAN Overweight | JP Morgan Chase & Co. | |
| 16.01.24 | SAFRAN Neutral | UBS AG | |
| 15.01.24 | SAFRAN Hold | Deutsche Bank AG | |
| 12.01.24 | SAFRAN Overweight | Barclays Capital | |
| 09.01.24 | SAFRAN Overweight | Barclays Capital | |
| 11.12.23 | SAFRAN Overweight | JP Morgan Chase & Co. | |
| 08.12.23 | SAFRAN Hold | Deutsche Bank AG | |
| 06.12.23 | SAFRAN Overweight | JP Morgan Chase & Co. | |
| 20.11.23 | SAFRAN Buy | Goldman Sachs Group Inc. | |
| 13.11.23 | SAFRAN Overweight | Barclays Capital |
Aktuelle Aktienanalysen
| 04.11.25 | Ferrari Outperform | RBC Capital Markets | |
| 04.11.25 | Boeing Outperform | RBC Capital Markets | |
| 04.11.25 | Ryanair Overweight | Barclays Capital | |
| 04.11.25 | Vossloh Hold | Warburg Research | |
| 04.11.25 | AXA Buy | Goldman Sachs Group Inc. | |
| 04.11.25 | Novartis Neutral | UBS AG | |
| 04.11.25 | HUGO BOSS Neutral | UBS AG | |
| 04.11.25 | Scout24 Neutral | UBS AG | |
| 04.11.25 | Schaeffler Neutral | UBS AG | |
| 04.11.25 | Rolls-Royce Buy | UBS AG | |
| 04.11.25 | Nemetschek Neutral | UBS AG | |
| 04.11.25 | Evonik Neutral | UBS AG | |
| 04.11.25 | Befesa Hold | Deutsche Bank AG | |
| 04.11.25 | WACKER CHEMIE Hold | Deutsche Bank AG | |
| 04.11.25 | GSK Hold | Deutsche Bank AG | |
| 04.11.25 | Ryanair Buy | Deutsche Bank AG | |
| 04.11.25 | SAF-HOLLAND Buy | Warburg Research | |
| 04.11.25 | WACKER CHEMIE Buy | Warburg Research | |
| 04.11.25 | Volkswagen Buy | Warburg Research | |
| 04.11.25 | Evonik Hold | Warburg Research | |
| 04.11.25 | BP Neutral | JP Morgan Chase & Co. | |
| 04.11.25 | Schaeffler Buy | Warburg Research | |
| 04.11.25 | HUGO BOSS Buy | Warburg Research | |
| 04.11.25 | AT & S buy | Erste Group Bank | |
| 04.11.25 | Philips Neutral | JP Morgan Chase & Co. | |
| 04.11.25 | Befesa Buy | Hauck Aufhäuser Lampe Privatbank AG | |
| 04.11.25 | Schaeffler Neutral | JP Morgan Chase & Co. | |
| 04.11.25 | Nordex Underperform | RBC Capital Markets | |
| 04.11.25 | Schaeffler Hold | Jefferies & Company Inc. | |
| 04.11.25 | Fresenius Medical Care Sell | UBS AG | |
| 04.11.25 | Apple Neutral | UBS AG | |
| 04.11.25 | NORMA Group Add | Baader Bank | |
| 04.11.25 | HUGO BOSS Hold | Jefferies & Company Inc. | |
| 04.11.25 | HUGO BOSS Neutral | JP Morgan Chase & Co. | |
| 04.11.25 | HUGO BOSS Outperform | RBC Capital Markets | |
| 04.11.25 | Fresenius Medical Care Underperform | Jefferies & Company Inc. | |
| 04.11.25 | Philips Buy | UBS AG | |
| 04.11.25 | Fresenius Medical Care Underweight | JP Morgan Chase & Co. | |
| 04.11.25 | Evonik Overweight | JP Morgan Chase & Co. | |
| 04.11.25 | Nemetschek Underweight | JP Morgan Chase & Co. | |
| 04.11.25 | Porsche Automobil Neutral | UBS AG | |
| 04.11.25 | Nordex Buy | Jefferies & Company Inc. | |
| 04.11.25 | Philips Hold | Jefferies & Company Inc. | |
| 04.11.25 | Rheinmetall Market-Perform | Bernstein Research | |
| 04.11.25 | Evonik Hold | Jefferies & Company Inc. | |
| 04.11.25 | FRIEDRICH VORWERK Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 04.11.25 | MTU Aero Engines Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 04.11.25 | Ryanair Market-Perform | Bernstein Research | |
| 04.11.25 | Kering Underweight | Barclays Capital | |
| 04.11.25 | LVMH Moet Hennessy Louis Vuitton Equal Weight | Barclays Capital |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.